The role of iron in alcohol-mediated hepatocarcinogenesis

Advances in Experimental Medicine and Biology

Volumn 815, Issue , 2015, Pages 89-112

  Mueller, Sebastian ^a   Rausch, Vanessa ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Alcohol; Alcoholic liver disease; Carcinogenesis; Hemochromatosis; Hepatocellular carcinoma; HFE; Iron; Reactive oxygen species

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CD71 ANTIGEN; FERRITIN; IRON REGULATORY PROTEIN 1; ALCOHOL; IRON; REACTIVE OXYGEN METABOLITE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; IRON OVERLOAD; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MOLECULAR DYNAMICS; MUTAGENESIS; OVERALL SURVIVAL; PRIORITY JOURNAL; ANIMAL; COMPLICATION; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; METABOLISM; TOXICITY;

ANIMALS; ETHANOL; HUMANS; IRON; IRON OVERLOAD; LIVER DISEASES, ALCOHOLIC; LIVER NEOPLASMS; REACTIVE OXYGEN SPECIES;

EID: 84925339269     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-09614-8_6     Document Type: Article

References (46)

1. Seitz HK, Stickel F (2007) Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7: 599-612
2. Seitz HK, Mueller S (2011) Ethanol metabolism and its consequences. In: Anzenbacher P, Zanger U (eds) Metabolism of Drugs and Xenobiotics. Weinheim, Wiley
3. Mueller S, Millonig G, Seitz HK, Waite GN (2012) Chemiluminescence detection of hydrogen peroxide. In: Schipper H, Pantopoulos K (eds) Principles of Free Radical Biomedicine. Nova Publishers, New York
4. Mueller S, Millonig G, Seitz HK (2009) Alcoholic liver disease and hepatitis C: a frequently underestimated combination. World J Gastroenterol 15: 3462-3471
5. Cochrane J, Chen H, Conigrave KM, Hao W (2003) Alcohol use in China. Alcohol Alcohol 38: 537-542
6. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128
7. Powell LW (1975) The role of alcoholism in hepatic storage disease. In: Seixas FA, Williams K, Seggleston S (eds) Medical consequences of alcoholism. New York Academy of Sciences, New York
8. Finch SC, Finch CA (1955) Idiopathic hemochromatosis, an iron storage disease. A iron metabolism in hemochromatosis. Medicine (Baltimore) 34: 381-430
9. Sheldon JH (1935) Haemochromatosis. Oxford University Press, London
10. Bell ET (1955) The relation of portal cirrhosis to hemochromatosis and to diabetes mellitus. Diabetes 4: 435-446
11. Conrad ME, Berman A Jr, Crosby WH (1962) Iron kinetics in laennec's cirrhosis. Gastroenterology 43: 385-390
12. Tavill AS, Qadri AM (2004) Alcohol and iron. Semin Liver Dis 24: 317-325
13. Shoden A, Gabrio BW, Finch CA (1953) The relationship between ferritin and hemosiderin in rabbits and man. J Biol Chem 204: 823-830
14. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolff RK et al (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13: 399-408
15. Pascoe A, Kerlin P, Steadman C, Clouston A, Jones D, Powell L, Jazwinska E, Lynch S, Strong R (1999) Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation. Gut 45: 301-305
16. Sohda T, Takeyama Y, Irie M, Kamimura S, Shijo H (1999) Putative hemochromatosis gene mutations and alcoholic liver disease with iron overload in Japan. Alcohol Clin Exp Res 23: 21S-23S
17. Dostalikova-Cimburova M, Kratka K, Stransky J, Putova I, Cieslarova B, Horak J (2012) Iron overload and HFE gene mutations in Czech patients with chronic liver diseases. Dis Markers 32: 65-72
18. Chapman RW, Morgan MY, Laulicht M, Hoffbrand AV, Sherlock S (1982) Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig Dis Sci 27: 909-916
19. Bell H, Skinningsrud A, Raknerud N, Try K (1994) Serum ferritin and transferrin saturation in patients with chronic alcoholic and non-alcoholic liver diseases. J Intern Med 236: 315-322
20. Suzuki Y, Saito H, Suzuki M, Hosoki Y, Sakurai S, Fujimoto Y, Kohgo Y (2002) Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease. Alcohol Clin Exp Res 26: 26S-31S
21. Mueller S (2013) Non-invasive assessment of patients with alcoholic liver disease. Clin Liver Dis 2: 68-71
22. Mueller S (2013) The role of iron in alcoholic liver disease. Alcohol Alcohol 48: 6
23. Fenton HJ (1894) Oxidation of tartaric acid in presence of iron. J Chem Soc Trans 65: 899-910
24. Saran M, Michel C, Stettmaier K, Bors W (2000) Arguments against the significance of the Fenton reaction contributing to signal pathways under in vivo conditions. Free Radic Res 33: 567-579
25. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G (1996) Longterm survival in patients with hereditary hemochromatosis. Gastroenterology 110: 1107-1119
26. Ko C, Siddaiah N, Berger J, Gish R, Brandhagen D, Sterling RK, Cotler SJ, Fontana RJ, McCashland TM, Han SH, Gordon FD, Schilsky ML, Kowdley KV (2007) Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry. Liver Int 27: 1394-1401
27. Turlin B, Juguet F, Moirand R, Le Quilleuc D, Loreal O, Campion JP, Launois B, Ramee MP, Brissot P, Deugnier Y (1995) Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology 22: 446-450
28. Zacharski LR, Chow BK, Howes PS, Shamayeva G, Baron JA, Dalman RL, Malenka DJ, Ozaki CK, Lavori PW (2008) Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J Natl Cancer Inst 100: 996-1002
29. Hann HW, Stahlhut MW, Blumberg BS (1988) Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. Cancer Res 48: 4168-4170
30. Tsukamoto H, Horne W, Kamimura S, Niemela O, Parkkila S, Yla-Herttuala S, Brittenham GM (1995) Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96: 620-630
31. D'Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44: 217-231
32. Ganne-Carrie N, Christidis C, Chastang C, Ziol M, Chapel F, Imbert-Bismut F, Trinchet JC, Guettier C, Beaugrand M (2000) Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study. Gut 46: 277-282
33. Wang J, Pantopoulos K (2011) Regulation of cellular iron metabolism. Biochem J 434: 365-381
34. Andrews NC (1999) Disorders of iron metabolism. N Engl J Med 341: 1986-1995
35. Ganz T (2007) Molecular control of iron transport. J Am Soc Nephrol 18: 394-400
36. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, Vaulont S (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 98: 8780-8785
37. Theil EC (2003) Ferritin: at the crossroads of iron and oxygen metabolism. J Nutr 133: 1549S-1553S
38. Nemeth E, Ganz T (2009) The role of hepcidin in iron metabolism. Acta Haematol 122: 78-86
39. Hentze MW, Muckenthaler MU, Galy B, Camaschella C (2010) Two to tango: regulation of mammalian iron metabolism. Cell 142: 24-38
40. Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP (2007) Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J Leukoc Biol 82: 934-945
41. Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352: 1011-1023
42. Millonig G, Ganzleben I, Peccerella T, Casanovas G, Brodziak-Jarosz L, Breitkopf-Heinlein K, Dick TP, Seitz HK, Muckenthaler MU, Mueller S (2012) Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3). J Biol Chem 287: 37472-37482
43. Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA (2008) Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 48: 1420-1429
44. Ponka P, Beaumont C, Richardson DR (1998) Function and regulation of transferrin and ferritin. Semin Hematol 35: 35-54
45. Kawabata H, Yang R, Hirama T, Vuong PT, Kawano S, Gombart AF, Koeffler HP (1999) Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 274: 20826-20832
46. Kawabata H, Nakamaki T, Ikonomi P, Smith RD, Germain RS, Koeffler HP (2001) Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells. Blood 98: 2714-2719